Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
β Scribed by Harper, Lorraine (author);Morgan, Matthew D. (author);Walsh, Michael (author);Hoglund, Peter (author);Westman, Kerstin (author);Flossmann, Oliver (author);Tesar, Vladimir (author);Vanhille, Phillipe (author);De Groot, Kirsten (author);Luqmani, Raashid (author);Flores-Suarez, Luis Felipe (author);Watts, Richard (author);Pusey, Charles (author);Bruchfeld, Annette (author);Rasmussen, Niels (author);Blockmans, Daniel (author);Savage, Caroline O. (author);Jayne, David (author)
- Book ID
- 121445457
- Publisher
- BMJ Publishing Group
- Year
- 2011
- Tongue
- English
- Weight
- 188 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0003-4967
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Current therapies for antineutrophil cytoplasmic antibody (anca)-associated vasculitis are limited by toxicity. ## Objective: To compare pulse cyclophosphamide with daily oral cyclophosphamide for induction of remission. ## Design: Randomized, controlled trial. random assignments